FDA notifications. Abacavir package insert changes approved. Hypersensitivity, other issues addressed

AIDS Alert. 2008 Sep;23(9):102-4.
No abstract available

Publication types

  • Newspaper Article

MeSH terms

  • Dideoxynucleosides / adverse effects*
  • Drug Hypersensitivity*
  • Drug Labeling*
  • Humans
  • Reverse Transcriptase Inhibitors / adverse effects*
  • United States
  • United States Food and Drug Administration

Substances

  • Dideoxynucleosides
  • Reverse Transcriptase Inhibitors
  • abacavir